Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Sep 1;7(3):113-114.
doi: 10.18683/germs.2017.1115. eCollection 2017 Sep.

2-Drug regimens in HIV treatment: pharmacological considerations

David Back
Editorial

2-Drug regimens in HIV treatment: pharmacological considerations

David Back. Germs. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: DB has received honoraria for speaking or advising and research grants (to the institution) from AbbVie, Gilead, Janssen, Merck and ViiV.

References

    1. May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28:1193–202. - PMC - PubMed
    1. Lundgren JD, Gatell JM, Rockstroh JK, Furrer H. EACS Guidelines, version 8.2. London: European AIDS Clinical Society (EACS); 2017.
    1. Cahn P. Candidates for inclusion in a universal antiretroviral regimen: dolutegravir. Curr Opin HIV AIDS. 2017;12:318–23. - PubMed
    1. Margolis DA, Gonzalez-Garcia J, Stellbrink H-J, et al. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial. Lancet. 2017 pii: S0140-6736(17)31917-7. - PubMed

Publication types

LinkOut - more resources